How Hard Will Coronavirus Hit U.S., Global Economies?
COVID-19 poses serious risk of economic damage, possibly even a recession, even as its health impacts will be limited.


Markets are panicking about coronavirus. Should you? No. But the risks are serious. The virus itself is dangerous but not dire, based on the outbreaks that have happened so far. It’s highly infectious, but seems far less deadly than SARS, which killed about 10% of its victims. More people are likely to die of the seasonal flu this year than of coronavirus, based on recent trends.
The Federal Reserve is bound to cut interest rates. But that won’t do much. Availability of credit isn’t the problem. Any Fed cuts will be largely symbolic. Interest rates, short- and long-term, are likely to be depressed while the panic lasts. On employment, we see a modest effect: some layoffs, but the unemployment rate is unlikely to rise past 4% from its current 3.6%.
However bad the situation gets, the hit to global trade is already a given. Expect shortages of certain goods to begin by late March or April as inventories run out, especially so for electronics, ingredients for generic drugs and automotive parts.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The U.S. imports more than half of computers and electronics for smart phones, tablets and many other devices from Asia. So while it’s too early to know which particular products might be hurt most, if you’re in the market for a gadget like a new phone or virtual-reality headset, you might want to buy now. Similarly, if you rely on a generic drug, consider reaching out to your doctor to check on name-brand alternatives or getting a prescription for a longer supply. Oh, and garlic. With China providing 70% of the U.S. consumption, you might want to set some aside to keep enough zest in your cooking. In the longer run, expect businesses to rethink their global supply chains and bring more production home. We are already hearing of such plans in the works.
As for the stock market: Count on more volatility, with further selloffs on any bad news, and brief rallies on any hopeful news. How much lower stocks go is impossible to say. We advise exercising caution about making any big moves, either buying or selling. Sometimes during turbulent times, it’s best to sit tight.
So, where does this all end? With the development of a better virus test kit, drugs that can treat the effects and lower the death rate, and with a vaccine. Better test kits have been developed, but await production and distribution. Several possible vaccines have been proposed, and will soon begin human testing. But it is likely to be nine to 12 months before any vaccine will become widely available.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

David is both staff economist and reporter for The Kiplinger Letter, overseeing Kiplinger forecasts for the U.S. and world economies. Previously, he was senior principal economist in the Center for Forecasting and Modeling at IHS/GlobalInsight, and an economist in the Chief Economist's Office of the U.S. Department of Commerce. David has co-written weekly reports on economic conditions since 1992, and has forecasted GDP and its components since 1995, beating the Blue Chip Indicators forecasts two-thirds of the time. David is a Certified Business Economist as recognized by the National Association for Business Economics. He has two master's degrees and is ABD in economics from the University of North Carolina at Chapel Hill.
-
Dow Adds 238 Points as UnitedHealth, Caterpillar Pop: Stock Market Today
The lack of a September jobs report didn't seem to worry market participants, with the data delayed due to the ongoing government shutdown.
-
Kiplinger Quiz of the Week: Test Yourself on the Week's Stories
Quiz The Nike stock price, Amazon's settlement and the shutdown were all covered by Kiplinger this week — but why? How much do you know about the week's financial news?
-
Apple Readies for AI Upgrade with New iPhones
The Kiplinger Letter The tech giant has stumbled when it comes to artificial intelligence, but a new batch of iPhones will help it make headway.
-
Japan Enters a New Era of Risk and Reform
The Kiplinger Letter Japan has entered a pivotal moment in its economic history, undertaking ambitious policy and structural reforms to escape from decades of stagnation.
-
How Consumers Are Tinkering with Cutting-Edge AI
The Kiplinger Letter Companies launching artificial intelligence tools are jostling for consumer attention. Some products are already building a deep connection with users.
-
After Years of Stagnant Growth, Hope Emerges for EU Economy
The Kiplinger Letter Can a German fiscal push outweigh French political peril?
-
Small Businesses Are Racing to Use AI
The Kiplinger Letter Spurred on by competitive pressures, small businesses are racing to adopt AI. A recent snapshot shows the technology’s day-to-day uses.
-
How AI Puts Company Data at Risk
The Kiplinger Letter Cybersecurity professionals are racing to ward off AI threats while also using AI tools to shore up defenses.
-
AI Start-ups Are Rolling in Cash
The Kiplinger Letter Investors are plowing record sums of money into artificial intelligence start-ups. Even as sales grow swiftly, losses are piling up for AI firms.
-
What is AI Worth to the Economy?
The Letter Spending on AI is already boosting GDP, but will the massive outlays being poured into the technology deliver faster economic growth in the long run?